Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 668Carcinoma, Non-Small-Cell Lung 463Prostatic Neoplasms 390Neoplasms 384Lung Neoplasms 265Multiple Myeloma 246Colorectal Neoplasms 233Neoplasm Metastasis 217Melanoma 203Ovarian Neoplasms 166Leukemia, Myeloid, Acute 166Pancreatic Neoplasms 154Carcinoma, Renal Cell 141Squamous Cell Carcinoma of Head and Neck 140Lymphoma 135Brain Neoplasms 131Leukemia, Lymphocytic, Chronic, B-Cell 126Glioblastoma 126Lymphoma, Non-Hodgkin 123Recurrence 121Carcinoma, Hepatocellular 119Head and Neck Neoplasms 115Urinary Bladder Neoplasms 111Triple Negative Breast Neoplasms 110Stomach Neoplasms 109Precursor Cell Lymphoblastic Leukemia-Lymphoma 104Uterine Cervical Neoplasms 101Hematologic Neoplasms 101Lymphoma, Follicular 96Sarcoma 95

Interventions

Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Gastritis, Atrophic × 1 year × Clear all
NCT02782949 2026-04-21

Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
50 enrolled 10 charts
Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡